Annual Drug Patent Expirations for LEVITRA
Levitra is a drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this drug and three Paragraph IV challenges.
Drug patent litigation for LEVITRA.
This drug has forty-seven patent family members in thirty-one countries.
The generic ingredient in LEVITRA is vardenafil hydrochloride. Additional details are available on the vardenafil hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com